Recent Posts

1. 

   Corium closing doors - Rumor

   Would it shock anyone? Probably not. Get rid of the clowns running this company and Azstarys could be doing so much better. NBRx

   Corium

   anonymous

   Apr 16, 2024 at 8:13 AM

2. 

   Ultragenyx says Angelman therapy is working, but safety questions remain

   via Treatment appeared to result in functional and cognitive gains in people with the neurological disorder. Three participants experienced lower extremity weakness, however. article source

   Pharma/Biotech Companies - In the News

   cafead

   Apr 16, 2024 at 8:12 AM

3. 

   Humira biosimilar scripts take off

   via Prescribing of biosimilars for AbbVie's blockbuster rheumatoid arthritis drug Humira surged just over a week following a change in drug coverage by CVS Health. Why it matters: It marked one of the first major efforts to push biosimilar...

   Pharma/Biotech Companies - In the News

   cafead

   Apr 16, 2024 at 8:12 AM

4. 

   Bye bye Sumitomo

   So you are saying there is more coming? Maybe once they realize they are short that 50 million they want us to find.

   Sunovion

   anonymous

   Apr 16, 2024 at 8:08 AM

5. 

   Adam Fein

   You suck feinbag

   Bio Reference

   anonymous

   Apr 16, 2024 at 8:07 AM

6. 

   Suzanna ABL

   I hope you’ve left NVS since you seem incredibly bitter.

   Novartis

   anonymous

   Apr 16, 2024 at 8:07 AM

7. 

   Vaccines reorg?

   Contract driven initial success for Arexvy. Pfizer unfortunately catching up, and other RSV entries on the way.

   GlaxoSmithKline

   anonymous

   Apr 16, 2024 at 8:04 AM

8. + Show More